Enroll in MIT xPro Course through March 3rd!

Enroll in MIT xPro Course through March 3rd!

Our Principles of Biomanufacturing: Using Biotechnology to Manufacture Medicines online course has just launched. This six-week self-paced course offers scientists, chemists, researchers, program managers, and other biological medicine specialists an opportunity to build an integrated understanding of their role in biomanufacturing. ENROLL NOW!

NEWDIGS offers comment on CMS Proposed Rule supporting Value-Based Purchasing, July 20th, 2020

NEWDIGS offers comment on CMS Proposed Rule supporting Value-Based Purchasing, July 20th, 2020

On behalf of the NEWDIGS initiative / FoCUS Project, team members submitted comments on the recent CMS Proposed Rule supporting Value-Based Purchasing (VBP) (CMS-2482-P). With active input from an engaged set of our cross-sectoral members, we focused on the Proposed Rule as an important step forward in enabling outcomes-based contracting by addressing several Medicaid Best Price methodology challenges.…

Biotechnology in the Age of COVID-19 Webinar Series Launched, 4/19/2020

Biotechnology in the Age of COVID-19 Webinar Series Launched, 4/19/2020

In response to the COVID-19 pandemic, the Center for Biomedical Innovation has hosted a series of collaborative webinars focused on how the biomanufacturing industry is coping with COVID-19. These informal meetings will be a place where industry experts will share their organization’s response to the unique challenges now facing biomanufacturing operations. These meetings are open to…

Evidera Interviews MIT CBI's Gigi Hirsch, MD

Evidera Interviews MIT CBI's Gigi Hirsch, MD

Dr. Debra Schaumberg, Vice President, Scientific Affairs, Real-World Evidence at Evidera recently sat down with Dr. Hirsch to discuss the NEWDIGS initiative, the LEAPS project, and the hope for transformation of the healthcare ecosystem. NEWDIGS is an exciting and innovative approach to developing solutions for systemwide impediments to biomedical innovation and patient care. The noncompetitive,…

The Singapore-MIT Alliance for Research and Technology announces  a new effort in cell therapy manufacturing, CAMP!!

The Singapore-MIT Alliance for Research and Technology announces  a new effort in cell therapy manufacturing, CAMP!!

CBI will work on one of three flagship research projects under the Singapore-MIT Alliance for Research and Technology’s new program on Critical Analytics for Manufacturing Personalized-Medicine (SMART CAMP). This effort is supported by the Singapore National Research Foundation and will involve collaboration with leading universities and hospitals in Singapore. SMART News & Events, July 15, 2019 

The Bioprocessing Summit Interview with Paul Barone

The Bioprocessing Summit Interview with Paul Barone

Cambridge Healthtech Institute recently spoke with Dr. Paul Barone of Massachusetts Institute of Technology about Viral Safety and where the field and industry is headed in coming years. Dr. Barone is a speaker at the 3rd Annual Virus and Pathogen Clearance and Safety in Biologics which is taking place from August 24-25, 2017 in Boston,…